ArticleExperimental & molecular medicine2022

Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic degradation.

Wenjia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.